Archives

Ceretas Limited (CTS) has disclosed its corporate governance structure and compliance approach ahead of its admission to the official list of the Australian Securities Exchange. The company has adopted a comprehensive governance framework aligned with ASX Corporate Governance Principles and Recommendations (4th edition), with board approval granted on 19 May 2026. The disclosure outlines the company's board charter, committee structures, director appointment processes, and diversity policy, establishing the governance foundations for its listed entity status.

• July 21, 2026 05:00 PM AEST
• Aditi Sarkar

Spheria Emerging Companies Limited (ASX: SEC) has announced three fully franked monthly dividends of 1.1 cents per share, payable in July, August and September 2026. The dividends, fully franked at the corporate tax rate of 30%, are based on the company's current distribution policy of 1.5% of post-tax net tangible assets (NTA) per share, paid in three equal monthly instalments rather than a single quarterly payment. The announcement comes as the company's portfolio navigated a recovering market environment in the second quarter, with SEC's total cumulative dividends since its December 2017 listing set to reach 86.0 cents per share following these payments.

• July 21, 2026 05:00 PM AEST
• Anjali Anand

Ceretas Limited (ASX: CTS), a Brisbane-based therapeutic ultrasound developer, has reported interim financial results demonstrating substantial progress in its research and development activities during the half-year ended 31 December 2025. The company received $2.39 million in government funding from the Australian Government's MRFF CUREator+ Dementia & Cognitive Decline program to accelerate development of its next-generation therapeutic ultrasound device targeting Alzheimer's disease. With cash holdings of $2.89 million and a portfolio of licensed intellectual property, Ceretas is positioning itself for commercialisation of a portable, image-guided therapeutic ultrasound platform.

• July 21, 2026 05:00 PM AEST
• Mukul

Ceretas Limited (ASX: CTS) has implemented a comprehensive Employee Securities Incentive Plan designed to attract, retain and incentivise employees through equity participation. The plan allows the company to grant convertible securities, performance rights, and shares to eligible employees, aligning workforce interests with shareholder value creation. The initiative reflects a strategic focus on long-term employee engagement and talent retention in a competitive market.

• July 21, 2026 05:00 PM AEST
• Shwetambri Chauhan

Uranium names surged after Australia and India cleared an export pathway for Australian uranium to feed India's civilian nuclear programme. Paladin and Boss Energy led the cohort higher as the market recalibrated a demand outlook underpinned by a broader nuclear revival. Tickers used:ASX:PDN, ASX:BOE Alternate headline 1:Can the Australia-India deal reset uranium demand? Alternate headline 2:Uranium producers rally as export pathway opens

• July 21, 2026 05:00 PM AEST
• Sam

Woodside has firmed as supply worries lifted crude and stirred a rally across energy names, while commentary floated the group itself as a target. Attention now turns to delivery at its flagship gas project and disciplined use of the cash it generates. Tickers used:ASX:WDS Alternate headline 1:Could Woodside become a global major's next target? Alternate headline 2:Woodside firms as Scarborough nears first cargo

• July 21, 2026 04:59 PM AEST
• Sam

Santos has firmed on a supply-driven oil rally and a warmer view from the research desk, with Beach Energy riding the same wave across the mid-tier. The near-term story rests on crude and shipping worries, while the longer arc turns on gas demand and project delivery. Tickers used:ASX:STO, ASX:BPT Alternate headline 1:How far can Santos ride the oil supply scare? Alternate headline 2:Santos firms as crude jumps on shipping worries

• July 21, 2026 04:59 PM AEST
• Sam

Ceretas Limited (ASX: CTS), a newly incorporated medical device company, has completed its first financial reporting period from 21 October 2024 to 30 June 2025 with a board of experienced life sciences executives and university-affiliated researchers. The company was spun out from The University of Queensland's ultrasound research program and the Queensland Brain Institute, bringing non-invasive therapeutic ultrasound technology toward commercialisation. The announcement reveals the company's leadership structure and the appointment of senior figures with track records in scaling medtech ventures and navigating regulatory pathways.

• July 21, 2026 04:57 PM AEST
• Manish Choudhary

Ceretas Limited (ASX: CTS) has adopted a new constitution that establishes the governance framework for the company's operations as a listed entity on the Australian Securities Exchange. The updated constitution sets out the company's share capital structure, director powers, shareholder meeting procedures, and dividend policies. The document represents a comprehensive refresh of the company's constitutional governance ahead of its listing on the Official List.

• July 21, 2026 04:57 PM AEST
• Mukul

Vitura Health is scaling patient access through telehealth clinics, positioning itself as a connected hub across prescribers, pharmacists and suppliers rather than a single-product supplier. Acquisitions and recurring remote care support the model, though regulation and sector volatility continue to shape the pace of growth. Tickers used:ASX:VIT Alternate headline 1:Can Telehealth Cement Vitura Health's Market Position? Alternate headline 2:Vitura Health Expands Its Medicinal Cannabis Ecosystem

• July 21, 2026 04:57 PM AEST
• Sam